Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Contact lens legislation

This article was originally published in The Gray Sheet

Executive Summary

California Governor Gray Davis (D) signs bill Sept. 23 requiring ophthalmologists and optometrists to release contact lens prescriptions to patients. Sponsored by Lou Correa (D-Anaheim), AB 2020 is expected to help consumers buy their contacts through discount stores, mail order and online distributors. The bill also provides safeguards by requiring a valid prescription with an expiration date. On Sept. 4, lens maker J&J/Vistakon met with FDA, along with 1-800-Contacts and state attorneys general from Baltimore and New York, to discuss the firm's concerns about adequate eye care for lens wearers buying through alternative sources. The Federal Trade Commission will examine the issue during its Oct. 8-10 Internet anti-competition workshop in Washington, D.C. (1"The Gray Sheet" July 22, 2002, p. 11)...

You may also be interested in...



FTC, Contact Lens Stakeholders Mull Federal Prescription Verification Laws

The Federal Trade Commission is taking a closer look at how potential national rules for contact lens prescription verification may favor Internet eyecare sellers or traditional manufacturers

Internet Anti-Competition Project Brings Devices, Contacts Under FTC’s Eye

The Federal Trade Commission will highlight contact lens and other medical supply industries during an upcoming public workshop exploring possible anti-competitive efforts that restrict e-commerce

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017206

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel